Application 209105
- Type
- ANDA
- Sponsor
- LUPIN LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATOVAQUONE | ATOVAQUONE | SUSPENSION;ORAL | 750MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209105-001 | ATOVAQUONE | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | 2018-09-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | 2018-09-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | 2018-09-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A209105-001 | ATOVAQUONE | 750MG/5ML | SUSPENSION / ORAL | AB | 2018-09-11 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209105-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209105-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209105-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209105-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209105-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209105-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209105-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209105-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209105-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209105-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209105-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209105-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209105-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209105-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209105-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209105-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209105-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A209105-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A209105-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209105-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A209105-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A209105-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A209105-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A209105-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A209105-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A209105-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209105-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A209105-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A209105-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209105-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209105-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209105-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209105-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A209105-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A209105-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209105-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A209105-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A209105-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A209105-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atovaquone Oral Suspension | ATOVAQUONE | KVK-Tech, Inc. | b31ff20a-c363-4be0-9bc0-3081c163b63c | 2026-06-16 | Warnings, Adverse reactions | ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | AvKARE | 54423fee-da60-25dc-e063-6294a90a2552 | 2026-06-14 | Warnings, Adverse reactions | ATOVAQUONE ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Camber Pharmaceuticals, Inc. | 2445304e-4b4e-4358-b098-31f3c49c52ef | 2026-06-10 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| atovaquone | ATOVAQUONE | Glenmark Pharmaceuticals Inc., USA | 9045ba6f-938e-4717-bfa2-a3efe52f04cd | 2026-05-06 | Warnings, Adverse reactions | atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | PAI Holdings, LLC dba PAI Pharma | df6086d3-6100-422a-bf23-e9610027749b | 2026-04-30 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | Amneal Pharmaceuticals LLC | b7398fcf-522a-488a-8dd6-051561f62804 | 2026-04-29 | Warnings, Adverse reactions | ATOVAQUONE ATOVAQUONE |
| MEPRON | ATOVAQUONE | GlaxoSmithKline LLC | b426b6bf-f07e-4580-97ae-dfca1ddf5b8f | 2026-03-20 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone Oral Suspension | ATOVAQUONE | Kesin Pharma Corporation | 4a2e2c4b-85aa-9b30-e063-6294a90a7bd9 | 2026-02-06 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Golden State Medical Supply, Inc. | ddbfe1a9-df9b-79b0-e053-2995a90acc9b | 2025-12-17 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Bionpharma Inc. | bff4f4fc-6307-f414-e053-2a95a90ac0de | 2025-12-04 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Chartwell Governmental & Specialty RX, LLC. | e6770b85-54f8-4969-af02-7d81586be761 | 2025-11-07 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | American Health Packaging | 1a8a43a2-bc26-4ee5-aa35-22a5477a7129 | 2025-10-17 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE | AvPAK | 4124ad97-f6b9-8afb-e063-6294a90ab970 | 2025-10-14 | Warnings, Adverse reactions | ATOVAQUONE ATOVAQUONE |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | 40331de7-819e-5965-e063-6294a90ac91d | 2025-10-01 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Kesin Pharma | 16b69156-e5de-c601-e063-6394a90afeae | 2025-09-15 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| ATOVAQUONE | ATOVAQUONE ORAL SUSPENSION | Major Pharmaceuticals | 73e2297e-7cda-4abf-9fb7-8c67cb5638a3 | 2025-08-13 | Warnings, Adverse reactions | ATOVAQUONE |
| Atovaquone | ATOVAQUONE | ATLANTIC BIOLOGICALS CORP. | f99a8a0c-2b42-4da0-8f5a-e963fc619e8b | 2025-05-12 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Abon Pharmaceuticals, LLC | 2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd08 | 2025-05-12 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | Lohxa | ba3cad0d-cce9-424f-ba5c-557dba8bef12 | 2025-03-20 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
| Atovaquone | ATOVAQUONE | A2A Integrated Pharmaceuticals, LLC | 27d64592-5078-6122-e063-6394a90ae074 | 2025-01-02 | Warnings, Adverse reactions | Atovaquone ATOVAQUONE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0888 | Atovaquone | Atovaquone | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0888 | Atovaquone | Atovaquone | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0888 | Atovaquone | Atovaquone | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0888 | Atovaquone | Atovaquone | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0888 | Atovaquone | Atovaquone | Pharmaceutical Associates, Inc. | ANDA | Current |
| 68180-282 | Atovaquone | Atovaquone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-282 | Atovaquone | Atovaquone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-282 | Atovaquone | Atovaquone | Lupin Pharmaceuticals, Inc. | ANDA | Current |